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I084 THE BSRBR-PSA: PLANS AND PROGRESS

Gareth T. Jones 1 1 Epidemiology Group, University of Aberdeen, Aberdeen, UNITED KINGDOM
The plans for the BSR Biologics Register in Psoriatic Arthritis (BSRBRPsA) will be outlined: including the overall study design information on variables being collected and the key differences between the PsA register and the existing AS and RA registers. Crucially, as we gear up for the start of recruitment in summer 2018, information will be given on how centres can join, and recruit patients to the register. Disclosures: G.T.J. grants/research support; AbbVie, Pfizer, UCB. In this presentation, I will discuss the attributes and processes that can assist in the development of a career in clinical academia. Drawing on experiences from my own career and more importantly, from examples learned from others, I will highlight the key questions to ask and the best sources from which to seek answers. I will highlight the roles of mentorship, curiosity, perseverance and travel in my discussions. Above all I will emphasise the excitement and extraordinary privilege bestowed on those pursuing the academic career track! Disclosures: I.M. consultancies; Abbvie, Novartis, Leo, Novartis, Janssen, Lilly, UCB, BMS, Crescendo, AZ, Galapagos. Grants/ research support; BMS, Pfizer, UCB, Janssen, Crescendo, Abbvie, Boerhinger, Compugen, Celgene, AZ. 
I085 EXPERIENCE OF INVOLVING
I090 DEVELOPING A CAREER IN MEDICAL EDUCATION AND BECOMING A LEADER IN EDUCATION
I091 WHEN TO SCREEN PATIENTS FOR PULMONARY HYPERTENSION AND INTERPRETING THE RESULTS
David G. Kiely Juvenile idiopathic arthritis (JIA) is an umbrella term for any inflammatory arthritis with onset before the age of 16 that is not associated with another cause such as sepsis, malignancy etc. It affects 1:1000 children and at least 50% of young people with JIA continue to have active disease into adulthood. A working knowledge of JIA, its phenotypes and similarities/differences to adult inflammatory arthritits is necessary for all rheumatologists who will meet adults with JIA in their clinics. The International League against Rheumatism
